End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF)

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

End-stage renal disease (ESRD) is a debilitating, costly, and increasingly common condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with alternative models of incentives and benefits, collected under the International Study of Health Care Organization and Financing, a substudy within the Dialysis Outcomes and Practice Patterns Study. Variation in spending per ESRD patient is relatively small, but correlated with overall per capita health care spending. Remaining differences in costs and outcomes do not seem strongly linked to differences in incentives.

This is a preview of subscription content, log in to check access.

References

  1. Ansell D., Feest T. (1999). UK Renal Registry Report 1999. Bristol, The Renal Association

    Google Scholar 

  2. Ansell D., Feest T., Byrne C., Ahmad A. (2003). UK Renal Registry Report 2003. Bristol, The Renal Association

    Google Scholar 

  3. Aron D.C., Harper D.L., Shepardson L.B., Rosenthal G.E. (1998). Impact of risk-adjusting cesarean delivery rates when reporting hospital performance. Journal of the American Medical Association, 279(24): 1968–1972

    Article  Google Scholar 

  4. Ashton, T., & Marshall, M. R. (2007). The organization and financing of dialysis and kidney transplantation services in New Zealand. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9023-x

  5. Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) (2005). Registry Report. Adelaide: ANZDATA.

  6. Birkmeyer J.D., Sharp S.M., Finlayson S.R., Fisher E.S., Wennberg J.E. (1998). Variation profiles of common surgical procedures. Surgery, 124, 917–923

    Google Scholar 

  7. Birkmeyer J.D., Siewers A.E., Finlayson E.V.A., Stukel T.A., Lucas F.L., Batista I., Welch H.G., Wennberg D.E. (2002). Hospital volume and surgical mortality in the United States. New England Journal of Medicine, 346, 1128–1137

    Article  Google Scholar 

  8. Brooks J.M., Irwin C.P., Hunsicker L.G., Flanigan M.J., Chrischilles E.A., Pendergast J.F. (2006). Effect of dialysis center profit-status on patient survival: A comparison of risk-adjustment and instrumental variable approaches. Health Services Research, 41(6): 2267–2289

    Article  Google Scholar 

  9. Canadian Organ Replacement Register (2005). Treatment of end-stage organ failure in Canada 2002 and 2003. Ottawa: Canadian Institute for Health Information.

  10. Cass A., Chadban S., Craig J., Howard K., McDonald S., Salkeld G., White S. (2006). The economic impact of end stage kidney disease in Australia. Sydney, The George Institute for International Health

    Google Scholar 

  11. Ceballos M., Lopez-Revuelta K., Caracho R., Garcia Lopez F., Castro P., Gutierrez J.A., Martin-Martinez E., Alonso R., Bernabeu R., Lorenzo V., Arias M., Sierra T., Estebanez C., Lara M., Cleries M., Vela E., Garcia-Blasco M.J., Zurriaga O., Vazquez C., Sanchez-Casajus A., Rodado R., Ripio J., Asin J.L., Magaz A. (2005). Informe de diálisis y trasplante correspondiente al año 2002 de la Sociedad Española de Nefrología y Registros Autonómicos. Nefrologia, 25(2), 121–124, 126–129.

    Google Scholar 

  12. Chalky M., Macomson J.H. (1998). Contracting for health services with unmonitored quality. The Economic Journal, 108(449): 1093–1110

    Article  Google Scholar 

  13. Combe C., Pisoni R.L., Port F.K., Young E.W., Canaud B., Mapes D.L., Held P.J. (2001). Dialysis outcomes and practice patterns study: données sur l’utilisation des cathéters veineux centraux en hémodialyse chronique. Néphrologie, 22(8): 379–384

    Google Scholar 

  14. Conte F. (2004). Registro Italiano di Dialisi e Trapianto. Esperienza 1996–2001. Giornale Italiano di Nefrologia, 6, 561–567

    Google Scholar 

  15. Couchoud, C., Frimat, L., Aldigier, J. C., de Cornelissen, F., Dabot, C., Joyeuz, V., Labeeuw, M., Maheut, H., & Stengel, B. (2005). Incidence et évaluation des traitements de suppléance de l’insuffisance rénale chronique dans sept régions françaises en 2003. Bulletin Ėpidémiologique Hebdomadaire, 37–38, 188–190.

  16. Danovitch G.M., Cohen D.J., Weir M.R., Stock P.G., Bennett W.M., Christensen L.L., Sung R.S. (2005). Current status of kidney and pancreas transplantation in the United States, 1994–2003. American Journal of Transplantation, 5(4 Pt 2): 904–915

    Article  Google Scholar 

  17. Danzon, P. M., & Furukawa, M. F. (2003). Prices and availability of pharmaceuticals: Evidence from nine countries. Health Affairs, Web exclusive (October 29, 2003)W3, 521–536.

  18. Dawson D. (1994). Costs and prices in the internal market: Markets versus the executive management guideline. York, Centre for Health Economics. Working Paper n. 115.

    Google Scholar 

  19. De Negri A., Formica M., Cavagnino A. (1997). Valutazione dei costi dei trattamenti dialitici. Giornale Italiano di Nefrologia, 14, 325–329

    Google Scholar 

  20. De Vecchi A.F., Dratwa M., Wiedemann M.E. (1999). Healthcare systems and end-stage renal disease (ESRD) therapies—an international review: Costs and reimbursement/funding of ESRD therapies. Nephrology Dialysis Transplantation, 14(Supp 6): 34–41

    Google Scholar 

  21. Deutschen Arbeitsgemeinschaft für Klinische Nephrologie (DAGKN) (2006). Dialysestandard 2006. Mitteilungen für Klinische Nephrologie, XXXV. Retrieved December 28, 2006, at http://www.nephrologie.de/ Dialysestandar2006.pdf

  22. Dor A. (2004). Optimal price rules, administered prices and suboptimal prevention: Evidence from a Medicare program. Journal of Regulatory Economics, 25(1): 81–104

    Article  Google Scholar 

  23. Durand-Zaleski, I., Combe, C., & Lang, P. (2007). International Study of Health Care Organization and Financing for end-stage renal disease in France. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9025-8

  24. Frei, U., & Schober-Halstenberg, H-J. (2002). Annual report on dialysis treatment and renal transplantation in Germany for 2001/2002. Retrieved March 13, 2007, from http://www.quasi-niere.de/berichte/online/en/01/world.html

  25. Fukuhara, S., Yamazaki, C., Hayashino, Y., Higashi, T., Eichleay, M. A., Akiba, T., Akizawa, T., Saito, A., Port, F. K., & Kurokawa, K. (2007). The organization and financing of end-stage renal disease treatment in Japan. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9017-8

  26. Furniss A.L., Young E.W., Gillespie B.W., Akizawa T., Marshall M.R., Saito A., Wikström B., Keen M.L., Pisoni R.L. (2006). Catheter use predicts septicemia/endocarditis events for hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Journal of the American Society of Nephrology, 17, 588A

  27. Goodkin D.A., Bragg-Gresham J.L., Koenig K.G., Wolfe R.A., Akiba T., Andreucci V.E., Saito A., Rayner H.C., Kurokawa K., Port F.K., Held P.J., Young E.W. (2003). Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and The United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Journal of the American Society of Nephrology, 14(12): 3270–3277

    Article  Google Scholar 

  28. Green J., Passman L.J., Wintfeld N. (1991). Analyzing hospital mortality: The consequences of diversity in patient mix. Journal of the American Medical Association, 265, 1849–1853

    Article  Google Scholar 

  29. Groupement des Nephrologues Francophones de Belgique (GNFB). (2002). Registre de Néphrologie de la Communauté Français de Belgique: Rapport annuel d’activité des Centres no 9—Année 2001. Brussels, Belgium.

  30. Hakim R.M., Wingard R.L., Parker R.A. (1994). Effect of the dialysis membrane in the treatment of patients with acute renal failure. New England Journal of Medicine, 331(20): 1338–1342

    Article  Google Scholar 

  31. Harris, A. (2007). The organization and funding of the treatment of end-stage renal disease in Australia. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9018-7

  32. Hidai H. (2000). Need for an incentive-based reimbursement policy toward quality of care for dialysis care for dialysis patient management. Kidney International, 58, 363–373

    Article  Google Scholar 

  33. Hirth, R. A. (2007). The organization and financing of dialysis and kidney transplant care in the United States of America. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9019-6

  34. Hirth R.A., Tedeschi P.J., Wheeler J.R.C. (2001). Extent and sources of geographic variation in Medicare end-stage renal disease expenditures. American Journal of Kidney Diseases, 38(4): 824–831

    Google Scholar 

  35. Jacquelinet C., Savoye E., Kessler M., Durand D. (2005). Tendances et perspectives de la greffe rénale en France. Bulletin Ėpidémiologique Hebdomadaire, 37–38, 191–192. Retrieved November 6, 2006, at http://www.invs.sante.fr/beh/2005/37_38/beh_37_38_2005.pdf

  36. Jha V. (2004). End-stage renal disease in developing countries: The India experience. Renal Failure, 26(3): 201–208

    Article  Google Scholar 

  37. Japanese Society for Dialysis Therapy (JSDT) (2002). An Overview of Regular Dialysis Treatment in Japan (as of December 31, 2000) [in Japanese]. Tokyo: Japanese Society for Dialysis Therapy.

  38. Japanese Society for Dialysis Therapy (JSDT) (2005). An overview of regular dialysis treatment in Japan (as of December 31, 2003) [in Japanese]. Tokyo: Japanese Society for Dialysis Therapy.

  39. Japanese Society for Dialysis Therapy (JSDT) (2006). A review of regular dialysis treatment in Japan (as of December 31, 2004)[in Japanese]. Tokyo: Japanese Society for Dialysis Therapy [CD Rom].

  40. Kimura R. (1998). Organ transplantation and brain-death in Japan: Cultural, legal and bioethical background. Annals of Transplantation, 3(3): 55–58

    Google Scholar 

  41. Kleophas, W., & Reichel, H. (2007). International Study of Health Care Organization and Financing: Development of renal replacement therapy in Germany. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9020-0

  42. Laupacis A., Keown P., Pus N., Krueger H., Ferguson B., Wong C.M Muirhead N. (1996). A study of the quality of life and cost-utility of renal transplantation. Kidney International, 50, 235-242

    Article  Google Scholar 

  43. Lee H., Manns B., Taub K., Ghali W.A., Dean S., Johnson D., Donaldson C. (2002). Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. American Journal of Kidney Diseases, 40(3): 611–622

    Article  Google Scholar 

  44. Luño, J. (2007). The organization and financing of end-stage renal disease in Spain. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9021-z

  45. Macron-Noguès, F., Vernay, M., Ekong, E., Lemaire, N., Salanave, B., Marty, M., Revel, M., Fender, P., & Allemand, H. (2005). La prévalence de l’insuffisance rénale chronique terminale traitée par dialyse en France en 2003: L’enquête nationale Sros-IRCT. Bulletin Ėpidémiologique Hebdomadaire, 37–38, 182–184. Retrieved November 6, 2006, from http://www.invs.sante.fr/beh/2005/37_38/beh_37_38_2005.pdf

  46. Mandelbrot, D. (1999). High-flux dialysis. In The kidney transplant/dialysis association patient handbook. Retrieved April 25, 2006, at http://msl1.mit.edu/ESD10/kidneys/HndbkHTML/contents.htm

  47. Manns, B. J., Mendelssohn, D. C., & Taub, K. J. (2007). The economics of end-stage renal disease care in Canada: Incentives and impact on delivery of care. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9022-y

  48. Mapes, D. L., Bodfish, L. J., Pisoni, R. L., Rayner, H. C., Young, E. W., & Held, P. J. (2001). Predictors of staffing practices in hemodialysis (HD) facilities: Dialysis Outcomes and Practice Patterns Study (DOPPS). Journal of the American Society of Nephrology, 12, 337A.

  49. McNeill, D., & Coonan, C. (2006). Japanese flock to China for organ transplants. Japan Focus. Accessed December 8, 2006, at http://www.japanfocus.org/products/details/1818

  50. Mendelssohn D.C., Kua B.T., Singer P.A. (1995). Referral for dialysis in Ontario. Archives of Internal Medicine, 1555, 2473–2478

    Article  Google Scholar 

  51. Ministero della Salute, Centro Nazionale Trapianti. Attività donazione e trapianto 2004—dati al 31 dicembre 2004. Retrieved June, 2005, at http://www.ministerosalute.it/trapianti/normativa/statistiche.jsp

  52. Nakai S., Shinzato T., Sanaka T., Kikuchi K., Kitaoka T., Shinoda T., Yamazaki C., Sakai R., Omori H., Morita O., Iseki K., Kubo K., Tabei K., Masakane I., Fushimi K., Wada A., Miwa N., Akiba T. (2002). The current state of chronic dialysis treatment in Japan (as of December 31, 2000). Journal of the Japan Society of Dialysis Therapy, 35(7): 1155–1184

    Google Scholar 

  53. National Kidney Foundation (2000). Clinical practice guidelines for nutrition in chronic renal failure. Retreived January, 2007, at http://www.kidney.org/professionals/KDOQI/guidelines_updates/doqi_nut.html

  54. National Kidney Foundation (2006a). K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Retreived January, 2007, at http://www.kidney.org/professionals/KDOQI/guidelines_anemia/index.htm

  55. National Kidney Foundation (2006b). Clinical practice guidelines and clinical practice recommendations: 2006 updates for hemodialysis adequacy, peritoneal dialysis adequacy, and vascular access. Accessed January 2007 at http://www.kidney.org/professionals/KDOQI/guideline_upHD_PD_VA/va_guide8.htm

  56. NBVN (2002). Annual Report 2002. Edegem, Belgium: Nederlandstalige Belgische Vereniging voor Nefrologie.

  57. Nicholson, T., & Roderick, P. (2007). International Study of Health Care Organization and Financing of Renal Services in England and Wales. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9015-x

  58. OECD. (2005). OECD in figures 2005 edition: Health spending and resources. Paris: Organization for Economic Cooperation and Development. Retrieved October, 2006, at http://www.oecd.org/topicstatsportal/ 0,2647, en_2825_495642_2757088_1_1_1_1,00.html

  59. OECD (2006). Purchasing Power Parities (PPPs) for OECD countries 1980–2005. Paris: Organization for Economic Cooperation and Development. Retrieved October, 2006, at http://www.oecd.org/statisticsdata/0,2643,en_2649_34357_1_119656_1_1_1,00.html

  60. Pauly M.V. (1993). U.S. health care costs: The untold true story. Health Affairs, 12(3): 152–159

    Article  Google Scholar 

  61. Pauly M.V., Held P.J. (1990). Benign moral hazard. Journal of Health Economics, 9(4): 447–461

    Article  Google Scholar 

  62. Pine M., Norusis M., Jones B., Rosenthal G.E. (1997). Predictions of hospital mortality rates: A comparison of data sources. Annals of Internal Medicine, 126(5): 347–354

    Google Scholar 

  63. Pisoni, R. L., Albert, J. M., Elder, S. E., Ethier, J., Kimata, N., Krishnan, M., Rayner, H. C., Saito, A., Sands, J., Saran, R., Wolfe, R. A., & Port, F. K. (2005). Lower mortality risk associated with native arteriovenous fistula (AVF) and graft (AVG) use in patient and facility-level analyses: Results from the DOPPS. Journal of the American Society of Nephrology, 16, 259A.

    Google Scholar 

  64. Pisoni R.L., Gillespie B.W., Dickinson D.M., Chen K., Kutner M., Wolfe R.A. (2004). The Dialysis Outcomes and Practice Patterns Study: Design, data elements, and methodology. American Journal of Kidney Diseases, 44 (Suppl 2): S7–S15

    Article  Google Scholar 

  65. Pisoni, R. L., Young, E. W., Combe, C., Leavey, S. F., Greenwood, R. N., Hecking, E., Canaud, B. J., & F. (2001). Higher catheter use within facilities is associated with increased mortality and hospitalization: Results from DOPPS. Journal of the American Society of Nephrology, 12, 299A.

  66. Pontoriero, G., Pozzoni, P., Del Vecchio, L., & Locatelli, F. (2007). International Study of Health Care Organization and Financing of renal replacement therapy in Italy: An evolving reality. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9016-9

  67. Port F.K., Wolfe R.A., Hulbert-Shearon T.E., McCullough K.P., Ashby V.B., Held P.J. (2004). High dialysis dose is associated with lower mortality among women but not among men. American Journal of Kidney Diseases, 43(6): 1014–1023

    Article  Google Scholar 

  68. Rayner H.C., Pisoni R.L., Bommer J., Canaud B., Hecking E., Locatelli F., Piera L., Bragg-Gresham J.L., Feldman H.I., Goodkin D.A., Gillespie B., Wolfe R.A., Held P.J., Port F.K. (2004). Mortality and hospitalization in haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis Transplantation, 19(1): 108–120

    Article  Google Scholar 

  69. Saran R., Bragg-Gresham J.L., Levin N.W., Twardowski Z.J., Wizemann V., Saito A., Kimata N., Gillespie B.W., Combe C., Bommer J., Akiba T., Mapes D.L., Young E.W., Port F.K. (2006). Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney International, 69(7): 1222–1228

    Article  Google Scholar 

  70. Svenskt Register för Aktiv Uremivård (SRAU) (2003). Aktiv uremivård i sverige: 1991–2002. Retrieved February 19, 2007, from http://www.socialstyrelsen.se/NR/rdonlyres/AC1A8C40-F4B8-4297-A24B-E7671B8CC31E/0/kva023r03.pdf.

  71. Szczech L.A., Klassen P.S., Chua B., Hedayati S.S., Flanigan M., McClellan W.M., Reddan D.N., Rettig R.A., Frankenfield D.L., Owen W.F. Jr. (2006). Assocations between CMS’s clinical performance measures project benchmarks, profit structure, and mortality in dialysis units. Kidney International, 69(11): 2094–2100

    Article  Google Scholar 

  72. TRANSPLANeT (2007). The number of presently registered people. Community Data File, Japan Organ Transplant Network. Retrieved December 8, 2006, at http://translate.google.com/translate?hl=en&sl=ja&u= http://www.jotnw.or.jp/&sa=X&oi=translate&resnum=2&ct=result&prev=/search%3Fq%3Djapan%2 Borgan%2Btransplant%2Bnetwork%26hl%3Den%26lr%3D%26sa%3DG

  73. Twardowski Z.J. (2006). Dialyzer reuse—part II: Advantages and disadvantages. Seminars Dialysis, 19(3): 217–226

    Article  Google Scholar 

  74. U.S. Census Bureau (2006). International data base. Washington, DC: U.S. Census Bureau. Retrieved 18, 2006, at http://www.census.gov/ipc/www/idbnew.html

  75. USRDS (2005). Annual data report: Atlas of end stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases.

  76. Van Biesen, W., Lameire, N., Peeters, P., & Vanholder, R. (2007). Belgium’s mixed private/public health care system and its impact on the cost of end-stage renal disease. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9013-z

  77. Wennberg, J. E., Fisher, E. S, & Skinner, J. S. (2002). Geography and the debate over Medicare reform. Health Affairs, Supp Web Exclusives, W96–114.

  78. Wikström, B., Fored, M., Eichleay, M. A., & Jacobson, S. H. (2007). The financing and organization of medical care for patients with end-stage renal disease in Sweden. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9013-y

  79. Wolfe R.A., Ashby V.B., Milford E.L., Akinlolu O.O., Ettenger R.E., Agodoa L.Y.C., Held P.J., Port F.K. (1999). Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New England Journal of Medicine, 341, 1725–1730

    Article  Google Scholar 

  80. Wordsworth S., Ludbrook A. (2005). Comparing costing results in across country economic evaluations: The use of technology specific purchasing power parities. Health Economics, 14, 93–99

    Article  Google Scholar 

  81. World Bank (2004). GNI per capita 2002: Atlas method and PPP. World Development Indicators database. Retrieved April 6, 2007, at http://www.adoptadoctor.org/gni.pdf

  82. World Health Organization (2006). WHO Statistical Information System: Life tables for WHO member states. Retrieved December, 2006, at http://www3.who.int/whosis/life/life_tables/life_tables.cfm? path=life,life_tables&language=english

  83. Yoshino M., Kuhlmann M.K., Greenwood R.N., Pisoni R.L., Port F.K., Jager K.J., Homel P., Augustijn H., de Charro F.T., Collart F., Erek E., Finne P., Garcia-Garcia G., Grönhagen-Riska C., Ioannidis G.A., Ivis F., Leivestad T., Løkkegaard H., Lopot F., Jin D.C., Kotanko P., Kramar R., Nakao T., Nandakumar M., Ramirez S., van der Sande F.M., Schön S., Simpson K., Walker R.G., Zaluska W., Levin N.W. (2006). International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. Journal of the American Society of Nephrology, 17, 3510–3519

    Article  Google Scholar 

  84. Young E.W., Dykstra D.M., Goodkin D.A., Mapes D.L., Wolfe R.A., Held P.J. (2002). Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). International Society of Nephrology, 61, 2266–2271

    Google Scholar 

  85. Young E.W., Goodkin D.A., Mapes D.L., Port F.K., Keen M.L., Chen K., Maroni B.L., Wolfe R.A., Held P.J. (2000). The Dialysis Outcomes and Practice Patterns Study: An international hemodialysis study. Kidney International, 57(Suppl 74): S74–S81

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Avi Dor.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Dor, A., Pauly, M.V., Eichleay, M.A. et al. End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF). Int J Health Care Finance Econ 7, 73–111 (2007). https://doi.org/10.1007/s10754-007-9024-9

Download citation

Keywords

  • End-stage renal disease
  • Dialysis
  • Health care financing
  • Incentives
  • Medical costs
  • Reimbursement
  • Transplantation

JEL Classifications

  • I10
  • I11
  • I12
  • I18